Alzheimer's Association International Conference
Eisai Unveils Lecanemab’s Alzheimer’s Breakthrough at AAIC 2023
SG Tylor
Source – Eisai July 20, 2023 Biogen revealed the results of a comprehensive analysis of the Phase III Clarity AD ...
Donanemab Shows Significant Advance in Alzheimerās Treatment
SG Tylor
Source – Eli Lilly The full data from Eli Lilly’s TRAILBLAZER-ALZ 2 trial of the amyloid drug donanemab has validated ...
